These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 21424920)

  • 1. [Editorial].
    Butter C; Doll N
    Herzschrittmacherther Elektrophysiol; 2011 Mar; 22(1):3. PubMed ID: 21424920
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiac resynchronisation therapy for heart failure with narrow or normal QRS.
    Yip GW; Fung JW
    Heart; 2011 Jul; 97(13):1029-31. PubMed ID: 21343170
    [No Abstract]   [Full Text] [Related]  

  • 3. Coronary sinus atresia complicating cardiac resynchronization therapy.
    Nakamura T; Otomo K; Kawai S; Igawa O
    J Cardiovasc Electrophysiol; 2010 Oct; 21(10):1178. PubMed ID: 20522151
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cardiac resynchronization therapy. The electrophysiological contribution to the treatment of heart failure].
    Potratz J; Wiegand U
    Herzschrittmacherther Elektrophysiol; 2009 Sep; 20(3):99-101. PubMed ID: 19756818
    [No Abstract]   [Full Text] [Related]  

  • 5. Should we optimize cardiac resynchronization therapy during exercise?
    Bogaard MD; Kirkels JH; Hauer RN; Loh P; Doevendans PA; Meine M
    J Cardiovasc Electrophysiol; 2010 Nov; 21(11):1307-16. PubMed ID: 20550613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventive cardiac resynchronisation therapy.
    Klein HU
    Heart; 2012 Mar; 98(6):508-15. PubMed ID: 22350030
    [No Abstract]   [Full Text] [Related]  

  • 7. How Should Echocardiography Be Used in CRT Optimization?
    Hasan A
    J Am Soc Echocardiogr; 2010 Aug; 23(8):867-71. PubMed ID: 20659665
    [No Abstract]   [Full Text] [Related]  

  • 8. Interlead difference between T-peak to T-end intervals in resynchronization patients with an implantable cardioverter-defibrillator.
    Suzuki A; Shiga T; Nakai K; Futagawa K; Matsuyama Y; Shoda M; Kasanuki H; Hagiwara N
    J Electrocardiol; 2010; 43(6):706-12. PubMed ID: 20719332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [ Upgrading of cardiac resynchronization therapy devices in patients with heart failure--uprising clinical problem. ].
    Przybylski A
    Kardiol Pol; 2010 Nov; 68(11):1242. PubMed ID: 21108201
    [No Abstract]   [Full Text] [Related]  

  • 10. Cardiac resynchronization therapy: current trends and future directions.
    Jacob S; Bharadwaj AS; Panaich SS; Mathew A; Afonso L
    Minerva Cardioangiol; 2010 Dec; 58(6):717-29. PubMed ID: 21135811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal atrioventricular delay in CRT patients can be approximated using surface electrocardiography and device electrograms.
    Jones RC; Svinarich T; Rubin A; Levin V; Phang R; Murillo J; Sambelashvili A
    J Cardiovasc Electrophysiol; 2010 Nov; 21(11):1226-32. PubMed ID: 20522154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Echocardiographic mapping of left ventricular resynchronization during cardiac resynchronization therapy procedures.
    Chan NY; Choy CC; Cheung KC; Lau CL; Lo YK; Chu PS; Yuen HC; Lau ST; Choi YC
    Chin Med J (Engl); 2010 Jul; 123(13):1645-51. PubMed ID: 20819622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac resynchronization therapy improves exercise heart rate recovery in patients with heart failure.
    Okutucu S; Aytemir K; Evranos B; Aksoy H; Sabanov C; Karakulak UN; Kaya EB; Kabakci G; Tokgozoglu L; Ozkutlu H; Oto A
    Europace; 2011 Apr; 13(4):526-32. PubMed ID: 21076146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unmet Needs and Prioritization in Heart Failure.
    Lund LH; Hauptman PJ
    J Card Fail; 2016 Aug; 22(8):587-8. PubMed ID: 27346716
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiac resynchronization therapy in asymptomatic or mildly symptomatic heart failure patients in relation to etiology: results from the REVERSE (REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction) study.
    Linde C; Abraham WT; Gold MR; Daubert C;
    J Am Coll Cardiol; 2010 Nov; 56(22):1826-31. PubMed ID: 21087711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilization of defibrillators and resynchronization therapy at the time of evaluation at a heart failure and cardiac transplantation center.
    Sims DB; Garcia LI; Mignatti A; Colombo PC; Jones M; Uriel N; Mancini DM; Jorde UP
    Pacing Clin Electrophysiol; 2010 Aug; 33(8):988-93. PubMed ID: 20353413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of the gompertz method for evaluating survival gains in patients receiving cardiac resynchronization therapy.
    Messori A; Fadda V; Maratea D; Trippoli S
    J Am Coll Cardiol; 2014 Jul; 63(25 Pt A):2879. PubMed ID: 24814490
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardiac resynchronization therapy for chronic heart failure in China: guideline and practice.
    Hua W
    Chin Med J (Engl); 2010 Sep; 123(17):2293-4. PubMed ID: 21034536
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prevention of sudden death in heart failure patients: cardiac resynchronization therapy with or without defibrillation back-up].
    Pedretti RF; Laporta A; Masnaghetti S; Raimondo R; Salerno M; Santoro F; Vaninetti R
    G Ital Cardiol (Rome); 2010 Oct; 11(10 Suppl 1):134S-136S. PubMed ID: 21416844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing knowledge and changing views in cardiac resynchronization therapy.
    Buga L; Cleland JG
    Heart Fail Rev; 2012 Nov; 17(6):721-5. PubMed ID: 21932145
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.